SAINT HELIER (dpa-AFX) - Amphastar Pharmaceuticals Inc.'s (AMPH) key
over-the-counter epinephrine inhalation product candidate, Primatene Mist,
intended for temporary relief of mild asthma symptoms has once again failed to
get the FDA...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.